137 related articles for article (PubMed ID: 3392332)
21. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
Sager PT; Behboodikhah M
J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
[TBL] [Abstract][Full Text] [Related]
22. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
Duff HJ; Mitchell LB; Manyari D; Wyse DG
J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
[TBL] [Abstract][Full Text] [Related]
23. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of intravenous quinidine.
Swerdlow CD; Yu JO; Jacobson E; Mann S; Winkle RA; Griffin JC; Ross DL; Mason JW
Am J Med; 1983 Jul; 75(1):36-42. PubMed ID: 6859083
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
[TBL] [Abstract][Full Text] [Related]
26. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
[TBL] [Abstract][Full Text] [Related]
27. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
28. Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety.
Ho DS; Zecchin RP; Cooper MJ; Richards DA; Uther JB; Ross DL
Eur Heart J; 1995 Jan; 16(1):81-6. PubMed ID: 7737227
[TBL] [Abstract][Full Text] [Related]
29. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Saksena S; Rothbart ST; Shah Y; Cappello G
Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
[TBL] [Abstract][Full Text] [Related]
31. Phenytoin in the treatment of inducible ventricular tachycardia: results of electrophysiologic testing and long-term follow-up.
Epstein AE; Plumb VJ; Henthorn RW; Waldo AL
Pacing Clin Electrophysiol; 1987 Sep; 10(5):1049-57. PubMed ID: 2444929
[TBL] [Abstract][Full Text] [Related]
32. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
[TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
Steinbeck G; Bach P; Haberl R
J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
[TBL] [Abstract][Full Text] [Related]
36. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
[TBL] [Abstract][Full Text] [Related]
37. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
Gillis AM; Wyse DG; Duff HJ; Mitchell LB
J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
[TBL] [Abstract][Full Text] [Related]
38. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
[TBL] [Abstract][Full Text] [Related]
39. Quinidine pharmacodynamics in patients with arrhythmia: effects of left ventricular function.
Gillis AM; Mitchell LB; Wyse DG; McDonald M; Duff HJ
J Am Coll Cardiol; 1995 Apr; 25(5):989-94. PubMed ID: 7897143
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic testing in bundle branch block and unexplained syncope.
Morady F; Higgins J; Peters RW; Schwartz AB; Shen EN; Bhandari A; Scheinman MM; Sauvé MJ
Am J Cardiol; 1984 Sep; 54(6):587-91. PubMed ID: 6475778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
